Takeda Pharmaceutical Co Ltd ADR (TAK) — Capital Reinvestment Ratio
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow ($360.04 Billion) in capital expenditures ($42.57 Billion). See TAK equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Takeda Pharmaceutical Co Ltd ADR Capital Reinvestment Ratio (2000–2025)
This chart tracks Takeda Pharmaceutical Co Ltd ADR's Capital Reinvestment Ratio across 26 annual periods. Check Takeda Pharmaceutical Co Ltd ADR investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year Capital Reinvestment Ratio for Takeda Pharmaceutical Co Ltd ADR from 2000 to 2025. For live market cap and broader valuation context, see market cap of Takeda Pharmaceutical Co Ltd ADR.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $1.06 Trillion | $200.79 Billion | ▼ -71.7% |
| 2024 | 0.67x | $716.34 Billion | $480.73 Billion | ▲ +3.5% |
| 2023 | 0.65x | $977.16 Billion | $633.69 Billion | ▲ +291.5% |
| 2022 | 0.17x | $1.12 Trillion | $186.04 Billion | ▼ -29.2% |
| 2021 | 0.23x | $1.01 Trillion | $236.47 Billion | ▼ -28.0% |
| 2020 | 0.33x | $669.75 Billion | $217.71 Billion | ▼ -20.4% |
| 2019 | 0.41x | $328.48 Billion | $134.11 Billion | ▲ +20.3% |
| 2018 | 0.34x | $377.85 Billion | $128.26 Billion | ▼ -20.8% |
| 2017 | 0.43x | $261.36 Billion | $112.03 Billion | ▼ -87.1% |
| 2016 | 3.33x | $25.49 Billion | $84.86 Billion | ▲ +458.9% |
| 2015 | 0.60x | $182.52 Billion | $108.72 Billion | ▲ +12.5% |
| 2014 | 0.53x | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $158.96 Billion | $35.42 Billion | — |